A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification

Gallbladder cancer (GBC) is a highly invasive disease and the most prevalent malignancy of the biliary system. Patients with GBC are commonly diagnosed at a late stage and have an unfavorable prognosis. Palliative chemotherapy has been the standard care for recurrent or metastatic disease in the pas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hongna, Li, Xiaofen, Dai, Shuang, Shen, Xudong, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982584/
https://www.ncbi.nlm.nih.gov/pubmed/35693217
http://dx.doi.org/10.1093/pcmedi/pbab017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982584/
https://www.ncbi.nlm.nih.gov/pubmed/35693217
http://dx.doi.org/10.1093/pcmedi/pbab017

Ejemplares similares